PDF) Efficacy and Safety of Dulaglutide in the Treatment of Type 2 Diabetes: A Comprehensive Review of the Dulaglutide Clinical Data Focusing on the AWARD Phase 3 Clinical Trial Program
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies - Metabolism - Clinical and Experimental
Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis | Cardiovascular Diabetology | Full Text
Dulaglutide clinical trial program for data analysis | Download Scientific Diagram
Efficacy and safety of dulaglutide versus placebo and exenatide in type 2 diabetes (AWARD-1) - Virtual Meeting | EASD
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial - The Lancet
Clinical Trials: A1C, Weight Change & Cardiovascular Data | HCP | Trulicity (dulaglutide)
Key characteristics of completed trials and REWIND | Download Table
Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2) | SpringerLink
Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis | Cardiovascular Diabetology | Full Text
Efficacy and safety profile of once-weekly dulaglutide in type 2 diabe | DMSO
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial - The Lancet
Improvement in HbA1c in patients with type 2 diabetes mellitus treated with once weekly dulaglutide across baseline body mass index (BMI) subgroups at 26 or 52 weeks - Virtual Meeting | EASD
Clinical Trials: A1C, Weight Change & Cardiovascular Data | HCP | Trulicity (dulaglutide)
Preference for Oral and Injectable GLP-1 RA Therapy Profiles in Japanese Patients with Type 2 Diabetes: A Discrete Choice Experiment | SpringerLink
Dulaglutide Shows Sustained Reduction in Glycosylated Hemoglobin Values: 2-Year US Real-world Study Results - Clinical Therapeutics
Effects of Dulaglutide and Insulin Glargine on Estimated Glomerular Filtration Rate in a Real-world Setting - Clinical Therapeutics
Boan Biotech's Dulaglutide Injection (BA5101) Approved for Clinical Trials in China News - Boan Biotech，ShandongBoan Biotech， Boan Biotech Novel Antibodies，Boan Biotech Biosimilars，Bevacizumab
Mode of administration of dulaglutide: implications for treatment adhe | PPA
Clinical Outcomes by Albuminuria Status with Dulaglutide versus Insulin Glargine in Participants with Diabetes and CKD: AWARD-7 Exploratory Analysis | American Society of Nephrology
